IRIS UniCatt

D'Amico, Adele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.072
NA - Nord America 2.018
AS - Asia 1.038
SA - Sud America 315
AF - Africa 32
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.964
DE - Germania 647
SG - Singapore 377
SE - Svezia 362
CN - Cina 319
BR - Brasile 284
IT - Italia 278
IE - Irlanda 180
FR - Francia 150
UA - Ucraina 107
GB - Regno Unito 101
ID - Indonesia 71
IN - India 66
FI - Finlandia 63
RU - Federazione Russa 53
VN - Vietnam 29
NL - Olanda 26
TR - Turchia 26
CA - Canada 24
HK - Hong Kong 22
KR - Corea 22
BE - Belgio 19
BD - Bangladesh 18
PL - Polonia 16
AT - Austria 15
IR - Iran 15
MX - Messico 14
AR - Argentina 12
CH - Svizzera 11
IQ - Iraq 11
JP - Giappone 11
PK - Pakistan 9
CZ - Repubblica Ceca 8
MA - Marocco 8
PA - Panama 8
UZ - Uzbekistan 8
CI - Costa d'Avorio 7
ES - Italia 6
IL - Israele 6
LT - Lituania 6
ZA - Sudafrica 6
AU - Australia 4
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
PE - Perù 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AL - Albania 3
DK - Danimarca 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
RO - Romania 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
KE - Kenya 2
LV - Lettonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
Totale 5.483
Salva come PNG Salva come JPEG
Città #
Chandler 392
Singapore 251
Ashburn 174
Dublin 166
New York 119
San Mateo 72
Jakarta 71
Jacksonville 61
Milan 59
Houston 50
Munich 50
Rome 50
Wilmington 50
Boston 48
Hefei 44
Moscow 42
Nanjing 42
Nürnberg 40
Marseille 37
Bremen 30
Helsinki 30
Princeton 30
Woodbridge 29
Ann Arbor 28
Los Angeles 28
Chicago 26
Dearborn 26
Lawrence 23
São Paulo 23
Hong Kong 22
Seoul 22
Frankfurt am Main 21
Beijing 19
Seattle 19
Fairfield 18
Nuremberg 17
Lancaster 16
Changsha 15
Hebei 15
Izmir 15
Nanchang 15
Redwood City 15
Rio de Janeiro 14
Brussels 13
Cattolica 13
Inverigo 13
London 13
Boardman 12
Toronto 11
Washington 11
Düsseldorf 10
Hanoi 10
Norwalk 10
Paris 10
San Francisco 10
Detroit 9
Ho Chi Minh City 9
Leawood 9
Pune 9
Turku 9
Zhengzhou 9
Cambridge 8
Columbus 8
Kish 8
Lauterbourg 8
Palermo 8
Shenyang 8
University Park 8
Abidjan 7
Jinan 7
Menlo Park 7
Mountain View 7
Stockholm 7
Tashkent 7
Turin 7
Andover 6
Antwerp 6
Augusta 6
Belo Horizonte 6
Brooklyn 6
Buenos Aires 6
Charlotte 6
Guangzhou 6
Jiaxing 6
Naples 6
Redmond 6
Rignano Flaminio 6
Santa Clara 6
Shanghai 6
The Dalles 6
Tianjin 6
Vienna 6
Wroclaw 6
Angri 5
Bexley 5
Brno 5
Campinas 5
Council Bluffs 5
Curitiba 5
Goiânia 5
Totale 2.772
Salva come PNG Salva come JPEG
Nome #
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 270
Spinal muscular atrophy 208
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 142
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 141
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 121
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 114
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 111
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 109
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 108
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 104
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 103
null 103
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 101
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 95
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 94
The empowerment of translational research: lessons from laminopathies 90
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 90
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 88
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 87
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 86
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 85
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 84
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 84
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 83
Histological effects of givinostat in boys with Duchenne muscular dystrophy 81
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 81
MRI in sarcoglycanopathies: a large international cohort study 81
Type I SMA “new natural history”: long-term data in nusinersen-treated patients 81
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 80
Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita 76
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 76
Outcome of fetuses with congenital cytomegalovirus infection: a systematic review and meta-analysis 75
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 74
Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy 74
Longitudinal natural history in young boys with Duchenne muscular dystrophy 74
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study 71
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy 70
New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients 70
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. 70
Healthy design and urban planning strategies, actions, and policy to achieve salutogenic cities 70
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 70
Clinical Variability in Spinal Muscular Atrophy Type III. 69
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 66
Type I Spinal Muscular Atrophy patients treated with nusinersen: 4 year follow-up of motor, respiratory and bulbar function 64
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 62
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 62
The genetic basis of undiagnosed muscular dystrophies and myopathies 62
Development of an academic disease registry for spinal muscular atrophy 62
Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies 59
“Art, Colors, and Emotions” Treatment (ACE-t): A Pilot Study on the Efficacy of an Art-Based Intervention for People With Alzheimer’s Disease 58
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 58
MRI in sarcoglycanopathies: A large international cohort study 55
Gain and loss of abilities in type II SMA: A 12-month natural history study 55
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 54
An observational study of functional abilities in infants, children, and adults with type 1 SMA 53
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 53
Italian recommendations for diagnosis and management of congenital myasthenic syndromes 53
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 52
Long term follow-up of scoliosis progression in type II SMA patients 46
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 45
Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study 44
null 40
Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions. 39
Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1 39
Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study 38
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 37
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 36
A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy 35
Developmental lag of visuospatial attention in Duchenne muscular dystrophy 35
Mitochondrial Neurogastrointestinal Encephalomyopathy Presenting as Anorexia Nervosa 31
null 30
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy 30
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 29
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey 23
Insulin-like growth factor I in inclusion-body myositis and human muscle cultures 17
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 8
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 4
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 1
Totale 5.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021253 2 23 5 17 21 19 43 8 36 14 63 2
2021/2022526 32 17 9 46 27 26 9 77 37 39 109 98
2022/20231.218 124 152 79 197 84 146 80 97 133 36 62 28
2023/2024820 39 191 43 58 39 159 51 40 22 24 67 87
2024/20251.473 36 47 111 60 139 58 77 77 187 114 299 268
2025/2026231 231 0 0 0 0 0 0 0 0 0 0 0
Totale 5.579